LAVASEPT sol fl 500 ml

7680504451190 CH-50445 D08AC05 10.09.1.
LAVASEPT sol fl 500 ml
LAVASEPT sol fl 500 ml
LAVASEPT sol fl 500 ml
1 / 3
google

Details

Product number
5044502
CPT
-
Packaging group
500
Unit
ml
Composition
polihexanidum 0.4 mg, macrogolum 4000, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

Lavasept, gebrauchsfertige Verdünnung
gebrauchsfertige Verdünnung
500
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/06/2021
Professional SmPC
Français
17/06/2021
Professional SmPC
Italien
17/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
0.4 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

B. Braun Medical AG

6204 Sempach

Authorization information

Swissmedic authorization number
50445
Drug name
Lavasept, Lösung zur Anwendung auf der Haut
Galenic form
LSKU
ATC Code
D08AC05
Authorization status
Z
Dispensation category
B
First authorization
17/12/1991
Authorization expiration date
31/12/9999
IT number
10.09.1.
Domain
Human medicine
Field of application
Lokales Antiseptikum

Packaging details

Description (FR)
LAVASEPT sol fl 500 ml
Description (DE)
LAVASEPT Lös Fl 500 ml
Market launch
27/02/1996
Narcotic (BTM)
No

Other packaging sizes

LAVASEPT conc fl 100 ml
100 ML
View
LAVASEPT conc 5 amp 2 ml
None None
View
LAVASEPT sol fl 100 ml
100 ML
View
LAVASEPT sol fl 250 ml
250 ML
View
LAVASEPT sol fl 1000 ml
1000 ML
View